Experimental gene therapy treatment gives new hope to patients with sickle cell disease


The only cure for the painful genetic disorder is a bone marrow transplant, but a groundbreaking clinical trial involving gene therapy could change how sickle cell disease is treated. 21-year-old Manny had undergone hundreds of blood transfusions but is now symptom-free after taking part in the trial.